SCHEMBL2860104

SCHEMBL2860104

COC(=O)c1ccc2[nH]nc(-c3cnc4ccccc4c3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.53
PIM3 Q86V86 1/20 0.53
PIM2 Q9P1W9 1/20 0.53
ALOX15 P16050 1/20 0.52
HTT P42858 1/20 0.52
MAP2K4 P45985 2/20 0.48
ALPL P05186 1/20 0.46
MAPK1 P28482 4/20 0.46
MAPK3 P27361 2/20 0.45
DYRK1A Q13627 1/20 0.44
LRRK2 Q5S007 1/20 0.44
MAP4K4 O95819 1/20 0.44
CSNK1G2 P78368 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
MAP4K5 Q9Y4K4 1/20 0.44
CDK8 P49336 1/20 0.43
KDM4E B2RXH2 2/20 0.43
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2867324 0.86 PIM1 (0.56) PIM1PIM3PIM2MAP2K4MAPK1
SCHEMBL5373231 0.85 PIM1 (0.58) PIM1PIM3PIM2MAP2K4MAPK1
SCHEMBL2861069 0.84 ALPL (0.54) MAP2K4ALPLMAPK1MAPK3KDM4E
SCHEMBL2866668 0.81 ALOX15 (0.44) ALOX15HTTMAP2K4ALPLMAPK1
SCHEMBL2857271 0.79 MAPK1 (0.46) ALOX15HTTMAP2K4MAPK1MAPK3
SCHEMBL2864413 0.78 MAP2K4 (0.60) PIM1PIM3PIM2MAP2K4DYRK1A
SCHEMBL2863569 0.78 LRRK2 (0.56) PIM1PIM3PIM2ALOX15HTT
SCHEMBL9986229 0.77 MAPK1 (0.58) MAP2K4MAPK1MAPK3
SCHEMBL2867251 0.77 FGFR1 (0.54) MAP2K4MAPK1KDM4ENPC1ALDH1A1
SCHEMBL2860913 0.77 MAP2K4 (0.61) MAP2K4MAPK1MAPK3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PIM1 247/4885PIM3 236/4885PIM2 409/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 PIM1 194/4885PIM3 209/4885PIM2 388/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PIM1 247/4885PIM3 236/4885PIM2 409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.